Pride Yuri B, Buros Jacqueline L, Lord Erin, Southard Matthew C, Harrigan Caitlin J, Ciaglo Lauren N, Sabatine Marc S, Cannon Christopher P, Gibson C Michael
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
J Thromb Thrombolysis. 2008 Oct;26(2):106-12. doi: 10.1007/s11239-007-0075-z. Epub 2007 Jul 12.
Among patients with ST-segment elevation myocardial infarction (STEMI), evidence of restoration of both normal epicardial arterial flow and myocardial perfusion early after the administration of fibrinolytic agents has been associated with improved clinical outcomes. In STEMI patients treated with fibrinolytic therapy and scheduled for angiography later during hospital admission, however, the association of later indices of flow and perfusion with clinical outcomes has not been assessed.
Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 enrolled 3,491 STEMI patients treated with fibrinolytic therapy. Angiography was scheduled 48-192 h (median 84) after randomization. The Angiographic Perfusion Score (APS) (the sum of the TIMI Flow Grade and Myocardial Perfusion Grade before and after percutaneous coronary intervention (PCI), range of 0-12) was assessed in the 1,460 patients treated with PCI at late angiography, and its association with morbidity and mortality at 30 days was examined.
Full perfusion, defined as an APS of 10-12, was associated with the lowest mortality (0.8%), while partial perfusion (APS 4-9) (2.3%) and failed perfusion (APS 0-3) (18.0%) were associated with a higher incidence of mortality at 30 days (P < 0.001 for full perfusion vs. partial perfusion, P < 0.0001 for overall trend). In addition, full perfusion was associated with a lower incidence of recurrent myocardial infarction (MI), a composite of death and MI, recurrent myocardial ischemia, ventricular tachyarrhythmia, congestive heart failure and shock (P < 0.05 for all trends).
Among STEMI patients treated with late PCI following fibrinolytic therapy, higher APS is associated with reduced morbidity and mortality.
在ST段抬高型心肌梗死(STEMI)患者中,溶栓药物给药后早期正常心外膜动脉血流和心肌灌注恢复的证据与改善的临床结局相关。然而,在接受溶栓治疗并计划在住院后期进行血管造影的STEMI患者中,血流和灌注的后期指标与临床结局之间的关联尚未得到评估。
氯吡格雷作为心肌梗死溶栓辅助再灌注治疗(CLARITY-TIMI)28试验纳入了3491例接受溶栓治疗的STEMI患者。随机分组后48 - 192小时(中位数84小时)安排进行血管造影。在1460例接受晚期血管造影并接受经皮冠状动脉介入治疗(PCI)的患者中评估血管造影灌注评分(APS)(经皮冠状动脉介入治疗前后的TIMI血流分级和心肌灌注分级之和,范围为0 - 12),并检查其与30天发病率和死亡率的关联。
定义为APS为10 - 12的完全灌注与最低死亡率(0.8%)相关,而部分灌注(APS 4 - 9)(2.3%)和灌注失败(APS 0 - 3)(18.0%)与30天死亡率较高相关(完全灌注与部分灌注相比,P < 0.001;总体趋势P < 0.0001)。此外,完全灌注与复发性心肌梗死(MI)、死亡和MI的复合终点、复发性心肌缺血、室性快速心律失常、充血性心力衰竭和休克的发生率较低相关(所有趋势P < 0.05)。
在接受溶栓治疗后进行晚期PCI的STEMI患者中,较高的APS与发病率和死亡率降低相关。